Nazim Isma

发表

Upper extremity deep venous thrombosis in the population-based Malmö thrombophilia study (MATS). Epidemiology, risk factors, recurrence risk, and mortality.

A. Gottsäter, B. Lindblad, P. Svensson, 2010, Thrombosis research.

Procoagulatory changes induced by head-up tilt test in patients with syncope: observational study

R. Sutton, A. Fedorowski, K. Strandberg, 2017, Thrombosis Journal.

Higher levels of von Willebrand factor in patients with syncope due to orthostatic hypotension

O. Melander, R. Sutton, A. Fedorowski, 2015, Journal of hypertension.

Evaluation of recurrent venous thromboembolism in patients with Factor V Leiden mutation in heterozygous form.

A. Gottsäter, P. Svensson, Nazim Isma, 2012, Thrombosis research.

Diagnostic accuracy of troponin T measured ≥6h after symptom onset for ruling out myocardial infarction

T. Yndigegn, A. Khoshnood, Arash Mokhtari, 2019, Scandinavian cardiovascular journal : SCJ.

Ischemic stroke rates decline in patients with atrial fibrillation as anticoagulants uptake improves: A Swedish cohort study.

A. Själander, P. Svensson, N. Mochalina, 2017, Thrombosis research.

VENOUS THROMBOEMBOLISM IN SOUTHERN SWEDEN EPIDEMIOLOGY AND RISK FACTORS

Nazim Isma, 2012 .

Lipid-Lowering Therapy is Related to Inflammatory Markers and 3-Year Mortality in Patients With Critical Limb Ischemia

A. Gottsäter, B. Lindblad, I. Mattiasson, 2008, Angiology.

Socioeconomic factors and concomitant diseases are related to the risk for venous thromboembolism during long time follow-up

A. Gottsäter, B. Lindblad, J. Merlo, 2013, Journal of Thrombosis and Thrombolysis.

Does supervised exercise after deep venous thrombosis improve recanalization of occluded vein segments? A randomized study

A. Gottsäter, B. Lindblad, I. Mattiasson, 2007, Journal of Thrombosis and Thrombolysis.

The Factor V Leiden mutation is associated with a higher blood haemoglobin concentration in women below 50 of the Malmö Thrombophilia Study (MATS)

B. Lindblad, P. Svensson, Nazim Isma, 2009, Journal of Thrombosis and Thrombolysis.

Rate and risk factors for thromboembolism and major bleeding in adults with congenital heart disease taking vitamin K antagonist therapy

Daniel Samarai, J. Hlebowicz, S. Lindstedt, 2022, Thrombosis Update.

Prospective analysis of risk factors and distribution of venous thromboembolism in the population-based Malmö Thrombophilia Study (MATS).

A. Gottsäter, B. Lindblad, P. Svensson, 2009, Thrombosis research.

The effect of low molecular weight heparin (dalteparin) on duration and initiation of labour

B. Lindblad, P. Svensson, P. Lindqvist, 2010, Journal of Thrombosis and Thrombolysis.

Trends in Clinical Practice and Outcomes After Percutaneous Coronary Intervention of Unprotected Left Main Coronary Artery

J. Persson, S. Buccheri, G. Sarno, 2022, Journal of the American Heart Association.

Quality and predictors of oral anticoagulation therapy with vitamin K antagonists in adult congenital heart disease: TTR and INR variability.

Daniel Samarai, J. Hlebowicz, S. Lindstedt, 2021, Thrombosis research.

A retrospective study: elevation of cardiac troponin T after transcatheter closure of the interatrial septum is related to device size and procedural duration

U. Thilén, J. Hlebowicz, Nazim Isma, 2018, Journal of Congenital Cardiology.

Bivalirudin Versus Heparin Monotherapy in Elderly Patients With Myocardial Infarction

E. Omerovic, S. James, D. Erlinge, 2020, Circulation. Cardiovascular interventions.

Safety of Early hospital discharge following admission with ST-elevation myocardial infarction treated with percutaneous coronary intervention: a nationwide cohort study.

C. Gale, T. Jernberg, M. Mohammad, 2021, EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology.

Characteristics and outcomes in patients with atrial fibrillation and acute coronary syndrome treated with ticagrelor and novel oral anticoagulants

D. Erlinge, S. Koul, F. Holmqvist, 2021, Thrombosis Update.